Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
Rapport Therapeutics, a clinical-stage biotechnology firm focusing on small molecule precision medicines for neurological and psychiatric disorders, announced participation in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference with scheduled fireside chats in early June 2026. The company highlights…